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ABSTRACT 
 
Objective 
Leukaemia is the most common cancer of childhood, accounting for a third of cases. In order to assist 
clinicians in its early detection, we systematically reviewed all existing data on its clinical presentation 
and estimated the frequency of signs and symptoms presenting at or prior to diagnosis.  
 
Design 
We searched Medline and Embase for all studies describing presenting features of leukaemia in children 
(0-18 years) without date or language restriction, and, when appropriate, meta-analysed data from the 
included studies.  
 
Results 
We screened 12,303 abstracts for eligibility and included 33 studies (n=3084) in the analysis. All were 
cohort studies without control groups. 95 presenting signs and symptoms were identified and ranked 
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according to frequency. Five features were present in more than 50% of children: hepatomegaly (64%), 
splenomegaly (61%), pallor (54%), fever (53%) and bruising (52%). An additional 8 features were 
present in a third to a half of children: recurrent infections (49%), fatigue (46%), limb pain (43%), 
hepatosplenomegaly (42%), bruising/petechiae (42%), lymphadenopathy (41%), bleeding tendency 
(38%) and rash (35%). 6% of children were asymptomatic on diagnosis.  
 
Conclusions 
Over 50% of children with leukaemia have palpable livers, palpable spleens, pallor, fever or bruising on 
diagnosis. Abdominal symptoms such as anorexia, weight loss, abdominal pain and abdominal distension 
are common. Musculoskeletal symptoms such as limp and joint pain also feature prominently. Children 
with unexplained illness require a thorough history and focused clinical examination which should include 
abdominal palpation, palpation for lymphadenopathy, and careful scrutiny of the skin. Occurrence of 
multiple symptoms and signs should alert clinicians to possible leukaemia. 
 
 
  
Page 4 of 40
https://mc.manuscriptcentral.com/adc
Archives of Disease in Childhood
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
5 
 
MAIN TEXT 
 
 
What is already known on this subject 
 
• Serious illnesses such as cancer are rare in children in primary care (about 1 in 200 children) and 
are easily missed. 
 
• Leukaemia is the most common cancer of childhood, with 4000 new cases annually in the United 
States, and 450 in the United Kingdom.  
What this study adds  
 
• Over 50% of children with leukaemia have palpable livers, palpable spleens, pallor, fever or 
bruising on diagnosis.  
 
• Abdominal symptoms are not typically included in national cancer guidelines for identifying 
children with leukaemia, yet are present in 29% (anorexia/weight loss), 12% (abdominal pain) 
and 11% (abdominal distension) of children respectively.  
 
• Important common musculoskeletal and bleeding manifestations are also omitted, such as 
mucosal bleeding (25%), joint pain (11%) and limp (15%). 
 
 
INTRODUCTION 
 
In developed countries, cancer causes more childhood deaths than any other serious illness, including 
meningitis.
1
 Leukaemia is the most common malignancy of childhood, with an annual incidence of nearly 
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4000 in the United States (US), and 450 in the UK. and is responsible for a third of childhood cancer 
deaths.
2
 
2, 3
 Yet paediatric leukaemia is a low prevalence disease in primary care, emergency departments 
and general paediatrics settings. A general practitioner, for example, is likely to encounter a child with 
cancer only once every 20 years.
4
 The early presentation of paediatric leukaemia, with non-specific 
symptoms often mimicking the common, self-limiting illnesses, complicates the diagnostic challenge 
faced by front-line clinicians.
5, 6
  
 
Improving the early diagnosis of cancer is a key priority for many health services. The UK’s NHS Cancer 
Plan, for example, stipulates that all patients with suspected cancer, including children, should be seen by 
a specialist within two weeks of referral.
7
 Subsequent guidance from the National Institution for Health 
and Care Excellence (NICE) details a range of specific signs and symptoms which should alert clinicians 
to consider cancer in children and, in the case of leukaemia, take blood or immediately refer.
5
 Despite 
these attempts, the vast majority of cancers in children are still not diagnosed via the two week urgent 
referral pathway. In one recent study, 98% of childhood cancers in the UK were identified by other routes, 
such as direct presentations to Emergency Departments or non-urgent hospital referrals from primary 
care.
8
  
 
In order to improve our understanding of the early presentation of paediatric leukaemia, we aimed to 
systematically identify and collate all existing data on its presenting signs and symptoms at, or before, the 
point of diagnosis.  
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METHOD 
 
Search strategy 
We searched MEDLINE and EMBASE from inception to December 2014 using a combination of 
subject headings and free text incorporating the terms “leukaemia” and “diagnosis”, and limited to 
infants, children and adolescents. Reference lists of included studies were also searched for potentially 
relevant studies. No language restrictions were applied. The complete search strategy is detailed online 
(webappendix: eSearch). 
 
Study selection  
We considered for selection all primary research studies, either retrospective or prospective, of any 
study design (for example, cohort), describing the frequency of signs and symptoms at time of diagnosis 
for a minimum of ten children (0-18 years) with any type of leukaemia. Duplicate studies were removed. 
Studies which selected cases based on the presence of only certain clinical features of leukaemia (for 
example, only musculoskeletal or gastrointestinal manifestations) were excluded to avoid giving 
disproportionate weight to those features in the data synthesis. We also excluded studies which reported 
data on both adults and children, but where we were unable to extract the paediatric data. Any 
uncertainties regarding studies selection were discussed between the authors.   
 
One researcher (RC) screened titles and abstracts of all papers, excluding clearly irrelevant studies. Two 
researchers (RC and MT) independently reviewed the full text of remaining papers to assess eligibility. 
 
Quality assessment 
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Once we had assembled a short-list of studies eligible for potential inclusion using the criteria above, 
two reviewers (RC and MT) independently assessed the risk of bias in these studies’ results, to ensure 
that only those studies with an acceptable risk of bias were included in this review (webappendix: 
eTable1). There is no single, well-validated quality checklist for assessing retrospective cohort studies, 
and so we constructed a checklist based on relevant items from the MOOSE reporting guideline for 
observational studies
9
, the STROBE reporting guideline for cohort studies
10
, the Newcastle-Ottowa 
scale for non-randomised studies
11
 and CASP guidelines for case-control and cohort studies.
12,13 
  
 
Quality was assessed as “acceptable” or “unacceptable” in three domains: definition of leukaemia, 
selection of cases, and methods for extracting data on included cases. “Acceptable” for case definition 
required cases to be defined according to bone marrow findings. “Acceptable” for case selection 
required at least two of: participants’ baseline characteristics clearly documented; characteristics of 
cases representative of children with that type of leukaemia (i.e., the age and sex distribution of cases 
matched the known epidemiology of paediatric leukaemias); and the sample comprising all consecutive 
cases over the study period or, if non-consecutive, reasons for omission of cases documented. 
“Acceptable” for data extraction required use of a standardised data collection proforma and/or the 
objective measurement of signs (e.g. ultrasound confirmation of suspected organomegaly). 
Disagreements between the two reviewers were discussed with a third reviewer (AVDB). Only studies 
considered by all reviewers to pass in two or more domains were included in this review. 
 
Data extraction 
Data were extracted from included studies by one reviewer (RC) using a standardised proforma, and 
checked by a second reviewer (MT). We extracted study characteristics including period of study, 
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number and type of centres, study design, recruitment methods, sample size and age of children.  
Presenting signs and symptoms were recorded as described in each study, and numbers of children 
presenting with each feature noted. When a symptom or sign was not recorded in a study, no assumption 
was made about whether or not that feature had occurred in that population (i.e. we did not assume that 
absence of recording was equivalent to absence of that feature). Authors cross-checked each others’ 
data extraction to ensure accuracy. We did not contact authors of included papers for missing 
information. 
 
Statistical analysis 
We used STATA 11.1 to calculate simple proportions and standard errors of proportions for each 
presenting feature in each included study. Where considered clinically appropriate, features that the 
authors considered similar were aggregated (e.g. “petechiae”, “purpura” and “petechiae/purpura” were 
combined into a single category, “petechiae/purpura”). Features were not aggregated when it was not 
clinically sensible, or when they were reported with insufficient clarity to avoid possible double 
counting.  
 
We calculated pooled proportions of children presenting with each f ature using the metan command. 
Anticipating high heterogeneity between included studies, we performed random-effects meta-analysis 
using the DerSimonian and Laird method and standard methods to calculate I-squared as an estimate of 
the heterogeneity. In addition, we conducted three a priori subgroup analyses to explore reasons for 
heterogeneity and generate new hypotheses: (1) type of leukaemia; (2) year of publication; and (3) 
income status of the country in which the study was performed, as defined by Organisation for 
Economic Cooperation and Development (OECD) criteria at the time the study was conducted. We 
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conducted subgroup analyses based on type of leukaemia, country income level and publication date of 
study as, based on the existing literature, we felt that these might plausibly affect the speed of 
presentation of children, accessibility of health, care and changes in health-seeking behaviour, as well as 
the possibility of different clinical features depending on leukaemia type. We used exactly the same 
technique, DerSimonian and Laird, as for the main analyses. 
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RESULTS 
 
Search results 
After removal of duplicates, we identified 12,303 papers. We excluded 11,889 after screening titles and 
abstracts, and a further 381 after full text assessment (Figure 1). Reference lists of included studies did 
not yield additional eligible studies. There were no differences between authors regarding whether a 
particular study should be included. 
 
Characteristics of included studies 
35 studies met the eligibility criteria and were considered for inclusion, with two of these being 
excluded on quality grounds, as detailed below (webappendix: eTable1). The 33 included studies (
14-43
) 
were conducted in 21 countries, and described presenting symptoms and signs in a total of 3,084 
children (Table 1). All were retrospective cohorts of between 10 and 406 participants, and none 
compared cases with controls.  
 
The majority of studies (n=26) identified cases from medical records alone; others also used national 
and regional registries of childhood leukaemias (n=4), death certificat s (n=2), pathology reports (n=1), 
clinical trial data (n=1) and primary care records (n=1). All 33 studies extracted data from written 
hospital records. One study also obtained data from primary care records
42
, and another supplemented 
hospital records with data from a patient and/or parent-completed questionnaire.
43
 
 
Table 1: Characteristics of included studies 
   
Author  Country 
Period of 
study 
Source of data 
Sample 
size 
Age (years)   
  Median Mean Range   
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  All leukemias combined                 
  
 
Das (1973) India 1961-
1972 
Hospital records
1
 69 n/a n/a n/a 
  
  
 
Garcia Calatayud 
(2003) 
Spain 1995-
2000 
Hospital records
1
 29 n/a n/a n/a 
  
  
 
Hasanbegovic (2006) Bosnia 1997-
2003 
Hospital records
1
 130 6.3 n/a n/a 
  
  
 
Karimi (2008) Iran 1997-
2002  
Hospital records
3
 280 n/a n/a n/a 
  
  
 
La Grutta (1980) Italy 1960-
1978 
Hospital records
1
 334 3 6.1 0-15 
  
  
 
Meighan (1963) Canada 1948-
1960 
(a) Saskatchewan Cancer 
Commission records (b) 
Hospital records (c) Death 
certificates (d) Pathology 
reports
5
 
106 n/a n/a n/a 
  
  
 
Meighan (1964) United 
States 
1950-
1961 
(a) Hospital records (b) 
Death certificates
5
 
258 3.0 n/a 0-14 
  
  
 
Rajarajeswari (1980) India 1968-
1977 
Hospital records
1
 100 n/a n/a 0-11 
  
  
 
Thulesius (2000) Sweden 1984-
1995 
(a) Regional Tumour Registry 
(b) Hospital records (c) 
Primary care records
5
 
25 n/a 6.6 n/a 
  
  
 
Zahid (1996) Pakistan 1992-
1994 
(a) Hospital records (b) 
Parent/patient-completed 
data extraction form
1
 
62 n/a 8.1 n/a 
  
  All acute leukemias combined               
  
 
Biswas (2009) India 2003-
2005 
Hospital records
1
 75 n/a n/a 1.8-14 
  
  
 
Hassan (1992) India 1987-
1990 
Hospital records
1
 45 n/a n/a n/a 
  
  
 
Robazzi (2007) Brazil 1995-
2004 
Hospital records
1
 406 6.2 n/a 0.8-15 
  
  
 
Sinigaglia (2008) Italy 1984-
1999 
Hospital records
1
 122 5.6 6.6 0.7-
17.3 
  
  Acute lymphoid leukemias               
    (i) Acute lymphocytic leukemia (ALL)         
  
 
Atay (2005) Turkey 1993-
2000 
Hospital records
1
 34 n/a 5.8 2-14 
  
  
 
Bernbeck (2009) Germany 1995-
2004 
Hospital records
1
 189 5.8 n/a 0.1-
17.8 
  
  
 
Drozynsky (2002) Poland 1996-
2001 
Hospital records
1
 30 5 7.5 3-17 
  
  
 
Ma (1997) Hong Kong 1985-
1994 
Hospital records
1
 73 4.3 n/a 0.4-
14.2 
  
  Acute myeloid leukemias               
    (i) Acute myeloid leukemia (AML)        
  
 
Choi (1976) United 
States 
1962-
1973 
Hospital records
1
 171 8 n/a 0-22 
  
  
 
Klinowska (1992) Poland 1955-
1969 
Hospital records
1
 106 n/a n/a n/a 
  
  
 
Revesz (1985) Hungary 1971-
1982 
Leukemia Working Party 
Hospital records
6
 
123 n/a n/a n/a 
  
    (ii) Acute promyelocytic leukemia (APML)        
  
 
Chan (1981) United 
States 
1974-
1980 
Hospital records
2
 16 8.5 n/a 2-17 
  
  
 
Da Costa Moraes 
(2008) 
Brazil 2002-
2006 
Hospital records
1
 15 10 n/a 4-17 
  
    (iii) Acute megakaryocytic leukemia (AMKL)        
Page 12 of 40
https://mc.manuscriptcentral.com/adc
Archives of Disease in Childhood
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
13 
 
  
 
Paredes-Aguiler (2003) Mexico 1990-
2002 
Hospital records
1
 29 6.5 n/a 0.3-16 
  
  Chronic myeloid leukemias               
    (i) Chronic myeloid leukemia (CML)         
  
 
Castro-Malaspina 
(1983) 
France 1963-
1976 
Hospital records
1
 39 n/a n/a 2-16 
  
  
 
Chang (2003) Taiwan 1976-
2001 
Hospital records
1
 47 n/a n/a 2.7-17 
  
  
 
Liu (2010) China 1994-
2009 
Hospital records
1
 12 6.4 n/a 1.2-11 
  
  
 
Millot (2005) France 1991-
2003 
(a) Clinical trial data (b) 
Hospital records
4
 
40 12.5 n/a 1-18 
  
    (ii) Juvenile myelomonocytic leukemia  (JMML)        
  
 
Arico (1993) Italy 1983-
1992 
National Registry for JCML
6
 22 1.3 n/a 0-4 
  
  
 
Arya (1995) India 1980-
1991  
Hospital records
1
 10 n/a 1.7 0.3 - 
4.5 
  
  
 
Castro-Malaspina 
(1984) 
France 1954-
1977 
Hospital records
1
 38 n/a n/a 0.3-5.5 
  
  
 
Chang (2004) Taiwan 1978-
2001 
Hospital records
1
 16 n/a 2.5 0.7-4.0 
  
  
 
Owen (1992) United 
Kingdom 
1971-
1986 
(a) Childhood Cancer 
Research Group records (b) 
Hospital records
6
 
33 2.2 n/a 0.3-8.8 
  
  
 
        
  
   1  One hospital, 2 two hospitals, 3 three hospitals, 4 sixteen hospitals, 5 regionwide, 6 nationwide   
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Risk of bias of included studies 
All included studies defined cases using bone marrow criteria, and clearly documented participants’ 
baseline characteristics such as age and sex, which were consistent with the known epidemiology of 
paediatric leukaemias (webappendix: eTable1). Only 13 studies (39%) included all consecutive cases 
within the study period, with a further 3 studies (9%) describing why a proportion of potentially eligible 
cases were excluded. In the remaining 17 studies (4%), the proportion of consecutive cases included was 
unclear.  
 
One weakness of the included studies was lack of clarity about how the list of clinical features of 
leukaemia was generated, and at which point in the diagnostic pathway clinical features were recorded. 
Fifteen studies explicitly stated that they reported signs and symptoms occurring "at diagnosis", while 
two studies also reported symptoms from the point of symptom onset through to diagnosis. The 
remaining 16 studies were unclear as to whether the symptoms reported occurred at, and/or prior to 
diagnosis.  
 
Pooled frequencies of symptoms and signs from meta-analysis 
The number of different signs and symptoms reported in individual studies ranged from six to 23 
(median = 11). Overall, 95 separate signs and symptoms were reported. We were able to aggregate 15 
features into six over-arching categories. These were: petechiae/purpura (category derived from 
“petechiae”, “purpura” and “petechiae/purpura”), mucosal bleeding (including “mucosa  bleeding” and 
“bleeding gums”), anorexia/weight loss (including “anorexia”, weight loss” and “anorexia/weight loss”), 
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weakness/fatigue (including “weakness”, “fatigue”, “weakness/fatigue”), malaise/fatigue (including 
“malaise” and “malaise/fatigue”), and infections (including “infection” and “recurrent infections”).  
 
55 out of a possible 86 meta-analyses were conducted. For the remaining 31 features, meta-analysis was 
not required since the features were each present on only one study. The high heterogeneity (I
2
) statistics 
in the meta-analyses, (usually >90%), indicated that the degree of heterogeneity between studies was 
greater than expected by chance alone, confirmed the appropriateness of random effects meta-analysis to 
generate pooled proportions (Figure 2).  
 
The 36 features which were present in ≥10% of children are shown in Figure 2. We grouped these 
features into seven distinct clinical categories according to main underlying pathological process or 
body system affected: infiltrative, haemorrhagic, infective, systemic, musculoskeletal, gastro-intestinal 
and cutaneous. The most common infiltrative symptoms were hepatomegaly (64%) and splenomegaly 
(61%). Bruising, the most common haemorrhagic symptom, occurred in 52% of children. Fever (53%) 
was the most common infective symptom, and the most promiment musculoskeletal features were limb 
pain (43%) and bone pain (26%). Systemic features such as pallor (54%), and fatigue (46%) were also 
common. Finally, the most common gastrointestinal feature, anorexia/weight loss (29%) was present in 
almost a third of children. Those features reported in a third or more of children are summarised in 
Table 2, while those reported in < 10% of children are included in webappendix: eTable2. 
 
There were no data on the frequencies of combinations of symptoms, nor any data from control children. 
Nor was it possible to extract data on the timing of specific features, such as which presented first and 
last.   
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Table 2: Sign and symptoms present in more than one third of children with leukaemia 
          
  Presenting feature 
Frequency (%, pooled 
proportion)   
    
  Hepatomegaly 64   
  Splenomegaly 61   
  Pallor 54   
  Fever 53   
  Bruising 52   
  Infections 49   
  Fatigue 46   
  Limb pain 43   
  Hepatosplenomegaly 42   
  Bruising/petechiae 42   
  Lymphadenopathy 41   
  Bleeding tendency 38   
  Rash 35   
          
 
 
 
 
Subgroup analyses 
There were 14 specific features for which is was possible to calculate presenting frequencies across the 
subgroups ‘acute’ and ‘chronic’ leukaemia. (Figure 3). Certain features of acute illness, such as fever, 
were more common in acute leukaemia (62%, CI 51-73) than chronic leukaemia (31%, CI 13-49), 
whereas certain more progressive, infiltrative features, such as splenomegaly, were more prominent in 
chronic leukaemia (77%, CI 62-92) than acute (56%, CI 40-73)). Studies from high income settings also 
showed a greater prevalence of splenomegaly (76%, CI 67-85) compared with that in moderate/low 
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income settings (51%, CI 36-64). Conversely, other clinical features, such as fever, pallor, and 
anorexia/weight loss, were more common in low/moderate income settings (70%, CI 62-77, 73%, 15-52, 
43%, CI 14-73, respectively) than in high income settings (37%, CI 26-47, 34%, CI 15-52, 22%,  CI 15-
28) respectively). All three of the planned subgroup analyses (i.e. by leukaemia type, publication date, 
and income status of country) exhibited high heterogeneity, and most I
2
 statistics were >90% 
(webappendix: eTable3). We cannot exclude the difference in prevalence being due to confounding 
factors other than the subgroup criteria we selected.   
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DISCUSSION 
 
Principal findings  
 
We identified over 90 different presenting clinical signs and symptoms in children diagnosed with 
leukaemia. At time of diagnosis, over 50% of children with leukaemia have palpable livers, palpable 
spleens, pallor, fever or bruising, concurring with those features identified in current NICE guidance as 
potential alert symptoms for leukaemia.
5
 Our study also highlights several important potential omissions 
in NICE guidance. Abdominal symptoms, such as anorexia/weight loss (prevalence 29%), abdominal pain 
(12%) and abdominal distension (11%), do not feature in the NICE referral pathway for leukaemia. Nor do 
some of the haemorrhagic manifestations of leukaemia, such as mucosal bleeding, particularly from gums 
(25%). Instead, the guidance highlights only bruising and petechiae. Our results suggest this might be 
better replaced by ‘unusual bleeding’ phenomena to include all bleeding manifestations. Finally, although 
persistent/unexplained bone pain is highlighted in NICE guidance, other musculoskeletal manifestations of 
leukaemia, such as limp (11%), joint pain (15%) and functional impairment (23%), are unrepresented.  
 
Strengths and weakness  
This is the first systematic review to describe how leukaemia presents in childhood. It collates data from 
over 3,000 children in 33 studies from 21 different countries. Our review adhered to rigorous methods, 
including a systematic search strategy, unrestricted by date or language, and explicit inclusion criteria.
45
 
The findings therefore present the most comprehensive and internationally relevant data on presenting 
features available for clinicians worldwide.  
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The main limitations of the study reflect deficits in the design and reporting of the included studies. 
Although studies primarily collected contemporaneous data from medical case notes, all were conducted 
retrospectively. Given that included studies provided data on cases only, and not on controls, we were 
unable to determine diagnostic accuracy of clinical features.. The high heterogeneity between included 
studies, which was not accounted for by our a priori sub-group analyses, is unsurprising, given the lack of 
detail in most studies about how the list of presenting features was derived.  Without this, it is difficult to 
account for variations between studies in either the number of included features reported (which ranged 
from six to 23), or their frequencies. Additionally, the meta-analysis is complicated by inconsistent,  vague 
or ambiguous language used in individual studies to describe signs and symptoms (such as ‘bleeding 
tendency’). Conversely, some of the terms used clearly overlap to some degree (such as “bruising”, 
“bruising/petechiae”, “cutaneous bleeding”, “cutaneous/mucosal bleeding”, “petechiae/purpura”, all of 
which may or may not be identical to “bleeding tendency” in leukaemia), , which contributed to the 
analyses of an unwieldy 97 different presenting features.  
 
Comparison with existing literature 
Systematic reviews of the presentation of other main childhood cancers (such as central nervous system 
tumours) have also highlighted gaps in current protocols and guidelines which need to be addressed in 
updated guidelines.
47
 Qualitative studies indicate that even those symptom lists identified from systematic 
reviews may be incomplete, since they may fail to capture the full range of parent-reported symptoms, in 
which behavioural and affective changes in children feature prominently.
48
 
 
Implications for practice 
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Some of the most commonly presenting features we identified, such as fever, pallor and fatigue, also 
feature prominently in the presentation of many common, self-limiting diseases of childhood, and are 
therefore unlikely to assist frontline clinicians in discriminating between those children who do or do not 
have leukaemia. Others – hepatomegaly, splenomegaly, lymphadenopathy and petechiae, for example – 
are more specific for leukaemia, and hence of greater value as potential red flags. Our findings emphasise 
the importance, in any child with unexplained illness, of a focused clinical examination which should 
include abdominal palpation, examining for lymphadenopathy, and careful scrutiny of the skin. 
Abdominal palpation can be particularly challenging in children under five years, the peak presenting age 
group for paediatric leukaemia, but a palpable liver or spleen is an important red flag which should prompt 
urgent referral for further investigation. 
 
The lack of evidence on combinations of clinical signs and symptoms is disappointing, as research in other 
domains, such as serious infections in children, has shown that combining relatively non-specific features 
may result in useful prediction rules.
49
 We suggest that any child presenting with unusual symptom 
clusters, for example, bruising and fever or limb pain and pallor, should warrant an active search for other 
corroborative clinical features and consideration of a full blood count and blood film.  
 
Implications for future research 
Our study highlights three key limitations in the current evidence base for how paediatric leukaemia 
presents, which are priorities for future research in this area. First, we have no data on the frequency and 
time of onset of symptoms from the point of onset of the first symptoms at home, through to final 
diagnosis. Second, we do not know how frequently different symptom clusters occur, and whether 
different clusters occur at different time points in the illness trajectory prior to diagnosis. Third, we cannot 
Page 20 of 40
https://mc.manuscriptcentral.com/adc
Archives of Disease in Childhood
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
21 
 
estimate the diagnostic accuracy of individual or combinations of clinical features, as none of the included 
studies included data on control children. Large scale cohort studies using electronic routine data from 
primary care and hospital settings would address these gaps, though such studies are likely to be biased 
towards signs and symptoms already known to have a relation with leukaemia. An alternative and 
complementary approach could use qualitative methods to explore patients’, parents’ and clinicians’ 
accounts of the diagnostic process, generating a richer understanding of the potential determinants of 
delay.  
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Figure 1: Flow chart for selection of studies  
 
Initial search 
(n= 14963) 
Papers after duplicates removed 
(n=12303) 
Papers screened 
(n=12303) 
Full text papers assessed for eligibility 
(n=414) 
Papers included in synthesis 
(n=33) 
Papers excluded on 
title and abstract 
(n=11889) 
 
381 full text papers excluded: 
   70 had <10 cases 
   62 had no paediatric data 
   63 had no primary data 
   11 were inaccessible 
   157 had insufficient detail on signs and symptoms 
   16 had combined adult and pediatric data 
   2 were of insufficient quality for inclusion 
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Fig	  2:	  Frequency	  of	  signs	  and	  symptoms	  present	  in	  ≥	  10%	  in	  children	  with	  leukaemia	  
No.	  of	  patients	  
(studies)
Pooled	  proportion	  
(95%	  CI)
I	  squared
(p-­‐value)
Hepatomegaly 1431	  (27) 64	  (53-­‐75) 98	  (0)
Splenomegaly 1583	  (29) 61	  (48-­‐73) 98	  (0)
Hepatosplenomegaly 106	  (2) 42	  (24	  -­‐	  100) 100	  (0)
Lymphadenopathy 1135	  (32) 41	  (32	  -­‐	  51) 97	  (0)
Bruising 31	  (2) 52	  (37	  -­‐	  66) 20	  (0.27)
Bruising/petechiae 86	  (2) 42	  (36	  -­‐	  49) 0	  (0.57)
Bleeding	  tendency 544	  (19) 38	  (30	  -­‐	  46) 90	  (0)
Cutaneous/muscosal	  bleeding 52	  (2) 26	  (14	  -­‐	  38) 90	  (0)
Cutaneous	  bleeding 171	  (3) 26	  (14	  -­‐	  38) 92	  (0)
Petechiae/purpura 154	  (9) 25	  (14	  -­‐	  37) 92	  (0)
Mucosal	  bleeding	  (e.g.	  gums) 175	  (7) 25(16	  -­‐	  34) 91	  (0)
Epistaxis 13	  (3) 10	  (2	  -­‐	  18) 48	  (0.15)
Fever 1708	  (33) 53	  (45-­‐62) 97	  (0)
Infections 185	  (6) 49	  (16	  -­‐	  81) 99	  (0)
Respiratory	  symptoms 52	  (3) 22	  (1	  -­‐	  43) 97	  (0)
URTI 82	  (5) 20	  (9	  -­‐	  31) 85	  (0)
Sore	  throat 42	  (2) 11	  (3	  -­‐	  25) 95	  (0)
Limb	  pain 173	  (1) 43 n/a
Bone	  pain 425	  (15) 26	  (17	  -­‐	  35) 97	  (0)
MSK	  impairment 28	  (1) 23 n/a
Bone	  and/or	  joint	  pain 138	  (9) 19	  (13	  -­‐	  25) 76	  (0)
Joint	  pain 258	  (7) 15	  (5	  -­‐	  25) 96	  (0)
Limp 112	  (4) 11	  (0	  -­‐21) 94	  (0.05)
Pallor 1232	  (21) 54	  (40-­‐69) 99	  (0)
Fatigue 268	  (7) 46	  (28	  -­‐	  64) 97	  (0)
Malaise/fatigue 52	  (4) 31	  (7	  -­‐	  56) 96	  (0)
Weakness/fatigue 253	  (8) 27	  (18	  -­‐	  36) 94	  (0)
Oedema 29	  (3) 15	  (10	  -­‐	  20) 0	  (0.58)
Anorexia/weight	  loss 547	  (18) 29	  (16	  -­‐	  42) 98	  (0)
Abdominal	  symptoms 78	  (5) 20	  (9	  -­‐	  31) 89	  (0)
Abdominal	  pain 63	  (7) 12	  (7	  -­‐	  16) 49	  (0)
Gastro-­‐intestinal
Presenting	  feature
Infiltrative	  (organomegalies)
Haemorrhagic
Infective
Musculoskeletal	  (MSK)
Systemic
0	   10	   20	   30	   40	   50	   60	   70	   80	   90	   100	  
0	   10	   20	   30	   40	   50	   60	   70	   80	   90	   100	  
0	   10	   20	   30	   40	   50	   60	   70	   80	   90	   100	  
0	   10	   20	   30	   40	   50	   60	   70	   80	   90	   100	  
0	   10	   20	   30	   40	   50	   60	   70	   80	   90	   100	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Abdominal	  distension 30	  (5) 11	  (3	  -­‐	  18) 87	  (0.01)
Cutaneous
Rash 63	  (7) 35	  (22	  -­‐	  48) 72	  (0)
Pyoderma 3	  (1) 30 n/a
Nodules 3	  (1) 19 n/a
Skin	  infiltration 28	  (2) 12	  (0	  -­‐	  36) 97	  (0)
0	   10	   20	   30	   40	   50	   60	   70	   80	   90	   100	  
0	   10	   20	   30	   40	   50	   60	   70	   80	   90	   100	  	  	  	  	  	  	  	  	  Pooled	  propor\on	  	  	  
	  	  	  	  	  	  	  	  Non-­‐pooled	  propor\on	  
	  	  	  	  	  	  	  	  95%	  CI	  
Page 31 of 40
https://mc.manuscriptcentral.com/adc
Archives of Disease in Childhood
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
Confidential: For Review Only
ALL	  LEUKAEMIAS ACUTE	  LEUKAEMIAS CHRONIC	  LEUKAEMIAS
Pooled	  
proportion	  
(95%	  CI)
Pooled	  
proportion	  
(95%	  CI)
Pooled	  
proportion	  
(95%	  CI)
Hepatomegaly 64	  (53-­‐75) 71	  (59	  -­‐	  82) 54	  (28	  -­‐	  79)
Splenomegaly 61	  (48-­‐73) 56	  (40	  -­‐	  73) 77	  (62	  -­‐	  92)
Pallor 54	  (40-­‐69) 60	  (44	  -­‐	  76) 57	  (0	  -­‐	  100)
Fever 53	  (45-­‐62) 62	  (51	  -­‐	  73) 31	  (13	  -­‐	  49)
Lymphadenopathy 41	  (32	  -­‐	  51) 52	  (42	  -­‐	  62) 26	  (7	  -­‐	  46)
Bleeding	  tendency 38	  (30	  -­‐	  46) 48	  (34	  -­‐	  61) 27	  (19	  -­‐	  35)
Malaise/fatigue 31	  (7	  -­‐	  56) 32	  (0	  -­‐	  87) 31	  (0	  -­‐	  64)
Anorexia/weight	  loss 29	  (16	  -­‐	  42) 31	  (15	  -­‐	  48) 19	  (13	  -­‐	  26)
Bone	  pain 26	  (17	  -­‐	  35) 23	  (19	  -­‐	  26) 16	  (3	  -­‐	  36)
Petechiae/purpura 25	  (14	  -­‐	  37) 30	  (19	  -­‐	  40) 6	  (0	  -­‐	  17)
URTI* 20	  (9	  -­‐	  31) 6	  (0	  -­‐	  12) 19	  (0	  -­‐	  41)
Abdominal	  symptoms 20	  (9	  -­‐	  31) 21	  (3	  -­‐	  34) 38	  (24	  -­‐	  52)
Bone	  and/or	  joint	  pain 19	  (13	  -­‐	  25) 19	  (11	  -­‐	  28) 19	  (8	  -­‐	  30)
Abdominal	  distension 11	  (3	  -­‐	  18) 30	  (0	  -­‐	  84) 9	  (1	  -­‐	  16)
Figure	  3:	  Frequency	  of	  signs	  and	  symptoms	  in	  children	  according	  to	  leukaemia	  type
Presenting	  feature
*	  Upper	  respiratory	  
tract	  infection
0	   10	   20	   30	   40	   50	   60	   70	   80	   90	   100	   0	   10	   20	   30	   40	   50	   60	   70	   80	   90	   100	   0	   10	   20	   30	   40	   50	   60	   70	   80	   90	   100	  
	  	  	  	  	  	  	  	  Pooled	  proporTon	  	  	  
	  	  	  	  	  	  	  	  Non-­‐pooled	  proporTon	  
	  	  	  	  	  	  	  	  95%	  CI	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Supplement 
 
Presentation of childhood leukemia: systematic review and meta-analysis 
 
Rachel T Clarke
1
, Chris Mitchell
2
, Bob Phillips
3
, Ann Van den Bruel
1 
, Clare Bankhead
1
, Matthew J Thompson
1
 
 
 
 
eSearch: Electronic database search strategy 
 
A. Medline search strategy for leukaemia (last conducted Dec 2014) 
 
1. leukemia/ or exp leukemia, lymphoid/ or exp leukemia, myeloid/ 
2. (leukemia* or leukaemia*).tw. 
3. 1 or 2 
4. (sign or signs or symptom*).tw. 
5. ((clinical or biological or physical) adj5 (feature* or present* or characteristic* or manifestation*)).tw. 
6. (present* adj5 (feature* or characteristic*)).tw. 
7. present*.ti. 
8. 4 or 5 or 6 or 7 
9. 3 and 8 
10. (child* or infan* or toddler* or adolescen* or teenage* or pediatric* or paediatric*).tw. 
11. adolescent/ or exp child/ or exp infant/ 
12. 11 or 10 
13. 9 and 12 
 
B. Medline search strategy for cancer (last conducted Dec 2014): 
 
1. (cancer* or neoplasm* or tumor* or tumour* or malignan*).ti. 
2. (child* or adolescen* or teenage* or infan* or toddler* or pediatric* or paediatric*).ti. 
3. 1 and 2 
4. (sign or signs or symptom*).tw. 
5. ((clinical or biological or physical) adj5 (feature* or present* or characteristic* or manifestation*)).tw. 
6. (present* adj5 (feature* or characteristic*)).tw. 
7. present*.ti. 
8. 4 or 5 or 6 or 7 
9. 8 and 3 
 
C. Embase search strategy for leukaemia (last conducted Dec 2014) 
 
1. exp Leukemia/ 
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2. (leukemia* or leukaemia*).tw. 
3. 1 or 2 
4. (sign or signs or symptom*).tw. 
5. ((clinical or biological or physical) adj5 (feature* or present* or characteristic* or manifestation*)).tw. 
6. (present* adj5 (feature* or characteristic*)).tw. 
7. clinical feature/ or symptom/ 
8. present*.ti. 
9. 4 or 5 or 6 or 7 or 8 
10. (child* or infan* or toddler* or adolescen* or teenage* or pediatric* or paediatric*).tw. 
11. groups by age/ or adolescent/ or child/ or preschool child/ or school child/ or infant/ 
12. 11 or 10 
13. 9 and 12 and 3 
 
D. Embase search strategy for cancer (last conducted Dec 2014) 
 
1. exp Cancer/ 
2. cancer*.tw. 
3. 1 or 2 
4. (sign or signs or symptom*).tw. 
5. ((clinical or biological or physical) adj5 (feature* or present* or characteristic* or manifestation*)).tw. 
6. (present* adj5 (feature* or characteristic*)).tw. 
7. clinical feature/ or symptom/ 
8. present*.ti. 
9. 4 or 5 or 6 or 7 or 8 
10. (child* or infan* or toddler* or adolescen* or teenage* or pediatric* or paediatric*).tw. 
11. groups by age/ or adolescent/ or child/ or preschool child/ or school child/ or infant/ 
12. 11 or 10 
13. 9 and 12 and 3 
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eTable 1: Quality assessment of studies meeting eligibility criteria for potential inclusion 
 
STUDY 
1. CASE 
DEFINITION 
2. CASE SELECTION 3. DATA SELECTION 
INCLUDE 
PAPER? 
  
Adequate 
defn? 
(=bone 
marrow 
criteria)    
Overall 
acceptable 
/not 
Clear baseline 
characteristics? 
(eg. 
participants’ 
age and sex) 
Representative 
cohort?  
Adequate 
ascertainment? 
(eg. 
consecutive 
cases?) 
Overall 
acceptable/ 
not 
Standardised 
collection? 
(=use of 
proforma) 
Objective 
measurement? 
(eg. 
ultrasound 
findings) 
Overall 
acceptable/ 
not 
Ali Al-
Barazanchi 
(2005) 
Y Y Y Unclear Unclear N Unclear Unclear N N 
Arico (1993) Y Y Y Y Unclear Y Unclear Unclear N Y 
Arya (1995) Y Y Y Y Y Y Unclear Y Y Y 
Atay (2005) Y Y Y Y Unclear Y Unclear Unclear N Y 
Bernbeck 
(2009) 
Y Y Y Y Y Y Unclear Y Y Y 
Biswas (2009) Y Y Y Y Unclear Y Unclear Y Y Y 
Castro-
Malaspina 
(1983) 
Y Y Y Y Y Y Unclear Y Y Y 
Castro-
Malaspina 
(1984) 
Y Y Y Y Y Y Unclear Y Y Y 
Chan (1981) Y Y Y Y Unclear Y Unclear Unclear Y Y 
Chang (2003) Y Y Y Y Unclear Y Unclear Unclear Y Y 
Chang (2004) Y Y Y Y Unclear Y Unclear Y Y Y 
Choi (1976) Y Y Y Y Y Y Unclear Y Y Y 
Da Costa 
Moraes (2008) 
Y Y Y Y Y Y Unclear Unclear N Y 
Das (1973) Y Y Y Y Unclear Y Unclear Unclear N Y 
Drozynska 
(2002) 
Y Y Y Y Unclear Y Unclear Y Y Y 
Garcia 
Calatayud 
(2003) 
Y Y Y Y Unclear Y Unclear Unclear N Y 
Grimes (2007) N N Y Y Y Y Unclear Unclear N N 
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37
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Hasanbegovic 
(2006) 
Y Y Y Y Unclear Y Unclear Unclear N Y 
Hassan (1992) Y Y Y Y Y Y Y Unclear Y Y 
Karimi (2008) Y Y Y Y Unclear Y Y Y Y Y 
Klinowska 
(1992) 
Y Y Y Y Unclear Y Unclear Unclear N Y 
La Grutta 
(1980) 
Y Y Y Y Unclear Y Y Y Y Y 
Liu (2010) Y Y Y Y Unclear Y Unclear Y Y Y 
Ma (1997) Y Y Y Y Y Y Unclear Unclear N Y 
Meighan 
(1963) 
Y Y Y Y Y Y Unclear Y Y Y 
Meighan 
(1964) 
Y Y Y Y Y Y Unclear Unclear N Y 
Millot (2005) Y Y Y Y Y Y Unclear Y Y Y 
Owen (1992) Y Y Y Y Y Y Unclear Y Y Y 
Paredes-
Aguilera 
(2003) 
Y Y Y Y Y Y Unclear Unclear N Y 
Rajarajeswari 
(1980) 
Y Y Y Y Unclear Y Unclear Unclear N Y 
Revesz (1985) Y Y Y Y Y Y Unclear Unclear N Y 
Robazzi 
(2007) 
Y Y Y Y Unclear Y Unclear Unclear N Y 
Sinigaglia 
(2008) 
Y Y Y Y Y Y Unclear Unclear Y Y 
Thulesius 
(2000) 
Y Y Y Y Y Y Unclear Unclear N Y 
Zahid (1996) Y Y Y Y Unclear Y Y Unclear Y Y 
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eTable 2: Signs and symptoms in children with leukemia with <10% prevalence 
 
  Feature 
Pooled 
proportion 
(%) 
(95% 
CI) 
No. of 
participants 
No. of 
studies 
  
  
     
  
  Zanthomata 9 (3 - 20) 9 3   
  Papilloedema 8 n/a 3 1   
  Melaena 7 n/a 5 1   
  Nausea/vomiting 7 (0 - 17) 7 2   
  Asymptomatic 6 (3 - 10) 24 6   
  Convulsions 6 n/a 6 1   
  Cough 6 (0 - 14) 8 3   
  Heart failure 6 (3 - 11) 3 2   
  Jaundice 6 (0 - 14) 9 2   
  CNS* symptoms 5 (2 - 8) 36 4   
  Headache 5 (3 - 7) 27 7   
  Menorrhagia 5 n/a 9 1   
  Night sweats 5 n/a 9 1   
  Chest pain 5 (2 - 8) 11 2   
  Gum hypertrophy 5 (1 - 10) 23 3   
  Neck swelling 5 (0 - 11) 15 3   
  Collapsed vertebra 4 n/a 1 1   
  Mediastinal mass 4 (2 - 5) 21 4   
  Sternal tenderness 4 n/a 3 1   
  SVCO** 4 n/a 10 1   
  Café au lait spots 4 (3-12) 3 2   
  Diarrhoea 4 (0 - 8 10 3   
  Back pain 3 n/a 1 1   
  Erythema nodosum 3 n/a 1 1   
  Paraplegia 3 n/a 2 1   
  Priapism 3 (0 - 5) 4 4   
  Visual disturbance 3 n/a 1 1   
  Dizziness 3 (1 - 4) 12 2   
  Haematuria 3 (0 - 6) 6 2   
  Amenorrhea 2 n/a 1 1   
  Ascites 2 (0 - 4) 7 4   
  Fracture 2 n/a 1 1   
  Hilar lymphadenopathy 2 n/a 8 1   
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  Mass 2 n/a 1 1   
  Hearing disturbance 2 (1 - 5) 2 2   
  Meningism 2 (0 - 5) 11 3   
  Pleural effusion 2 (0  -4) 3 2   
  Proptosis 2 (1 - 4) 11 3   
  Bladder dysfunction 1 n/a 1 1   
  Forearm masses 1 n/a 1 1   
  Haematemesis 1 n/a 1 1   
  Ovarian mass 1 n/a 2 1   
  CN*** palsy 1 (0 - 30 4 2   
  Mandibular swelling 1 (0 - 3) 6 3   
  Testicular manifestations 1 (1 - 2) 3 2   
  Osteomyelitis 0 n/a 1 1   
  Pericardial effusion 0 n/a 1 1   
  Pericarditis 0 n/a 1 1   
  Refusal to walk 0 n/a 2 1   
  Renal involvement  0 n/a 1 1   
              
 *Central nervous system      
 
** Superior vena cava 
obstruction      
 *** Cranial nerve      
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eTable 3: Subgroup analyses in children with leukemia by leukemia type, income status, and year of study 
                                  
     OVERALL SUBGROUP ONE: INCOME SUBGROUP TWO: AGE SUBGROUP THREE: LEUKEMIA 
TYPE 
          1. High income 
2. Middle/low 
income 
1. 1990 - current 2. > 1990 1. Acute 2. Chronic 
  Presenting feature 
Pooled 
proportion  
(95% CI) 
I2  
(p-
value) 
Pooled 
proportion 
(95% CI) 
I2 
(p-
value) 
Pooled 
proportion 
(95% CI) 
I2 
(p-
value) 
Pooled 
proportio
n (95% 
CI) 
I2 
(p-
value) 
Pooled 
proportio
n (95% 
CI) 
I2 
(p-
value) 
Pooled 
proportion 
(95% CI) 
I2 
(p-
value) 
Pooled 
proportion 
(95% CI) 
I2 
(p-
value) 
                                  
  Infiltrative (organomegalies) 
  
  
   
        
   
  
  
 
Hepatomegaly 64 (53-75) 98 (0) 63 (49 - 77) 96 (0) 65 (49 - 81) 98 (0) 
64 (50 - 
77) 
97 (0) 
65 (50 - 
79) 
97 (0) 71 (59 - 82) 95 (0) 
54 (28 - 
79) 
95 (0) 
  
 
Splenomegaly 61 (48-73) 98 (0) 76 (67 - 85) 93 (0) 51 (36 - 64) 98 (0) 
60 (43 - 
77) 
98 (0) 
62 (42 - 
83) 
99 (0) 56 (40 - 73) 98 (0) 
77 (62 - 
92) 
86 (0) 
  
 
Hepatosplenomegaly 
42 (24 - 
100) 
100 (0) 42 (0 - 100) 
100 
(0) 
n/a n/a n/a n/a n/a n/a 42 (0 - 100) 100 (0) n/a n/a 
  
 
Lymphadenopathy 41 (32 - 51) 97 (0) 36 (22 - 50) 98 (0) 47 (37 - 58) 93 (0) 
45 (33 - 
57) 
96 (0) 
35 (20 - 
50) 
98 (0) 52 (42 - 62) 92 (0) 26 (7 - 46) 93 (0) 
  
 
  
  
  
   
  
  
  
   
  
  Haemorrhagic 
  
  
   
  
  
  
   
  
  
 
Bruising 52 (37 - 66) 
20 
(0.27) 
n/a n/a n/a n/a n/a  n/a n/a n/a 52 (37 - 66) 
20 
(0.27) 
n/a n/a 
  
 
Bruising/petechiae 42 (36 - 49) 0 (0.57) n/a n/a 42 (36 - 49) 
0 
(0.57) 
n/a  n/a n/a n/a 42 (36 - 49) 
0 
(0.57) 
n/a n/a 
  
 
Bleeding tendency 38 (30 - 46) 90 (0) 33 (23 - 43) 85 (0) 42 (29 - 56) 93 (0) 
33 (25 - 
40) 
79 (0) 
47 (38 - 
56) 
81 (0) 48 (34 - 61) 88 (0) 
27 (19 - 
35) 
37 
(0.16) 
  
 
Cutaneous/muscosal bleeding 
  
n/a n/a n/a n/a n/a  n/a n/a n/a n/a n/a n/a n/a 
  
 
Cutaneous bleeding 26 (14 - 38) 92 (0) 26 (14 - 38) 92 (0) n/a n/a n/a  n/a 28 (8 - 48) 96 (0) 26 (14 - 38) 92 (0) n/a n/a 
  
 
Petechiae/purpura 25 (14 - 37) 92 (0) 25 (3 - 47) 96 (0) 25 (13 - 38) 83 (0) 
23 (10 - 
35) 
91 (0) 
34 (13 - 
55) 
91 (0) 30 (19 - 40) 85 (0) 6 (0 - 17) 39 (0.2) 
  
 
Mucosal bleeding (e.g. gums) 25 (16 - 34) 91 (0) 15 (9 - 21) 
75 
(0.01) 
38 (19 - 57) 89 (0) 
34 (16 - 
53) 
91 (0) n/a n/a 25 (6 - 34) 91 (0) n/a n/a 
  
 
Epistaxis 10 (2 - 18) 
48 
(0.15) 
n/a n/a 10 (2 - 18) 
48 
(0.15) 
10 (2 - 18) 
48 
(0.15) 
n/a n/a 11 (0 - 23) 
74 
(0.05) 
n/a n/a 
  
 
  
  
  
   
  
  
  
   
  
  Infective 
  
  
   
  
  
  
   
  
  
 
Fever 53 (45-62) 97 (0) 37 (26 - 47) 
95 
(0.04) 
70 (62 - 77) 90 (0) 
37 (26 - 
48) 
95 (0) 
70 (62 - 
77) 
90 (0) 
62 (51 - 
.73) 
95 (0) 
31 (13 - 
49) 
91 (0) 
  
 
Recurrent infections 49 (16 - 81) 99 (0) 48 (12 - 85) 99 (0) n/a n/a 
61 (55 - 
68) 
96 (0) 30 (0 - 84) 98 (0) 49 (16 - 81) 99 (0) n/a n/a 
  
 
Respiratory symptoms 22 (1 - 43) 97 (0) 22 (1 - 43) 97 (0) n/a n/a 24 (0 - 72) 95 (0) n/a n/a 22 (1 - 43) 97 (0) n/a n/a 
  
 
URTI 20 (9 - 31) 85 (0) 36 (23 - 49) 
13 
(0.28) 
12 (1 - 23) 86 (0) 20 (9 - 31) 85 (0) n/a n/a 6 (0 - 12) n/a 19 (0 - 41) 
74 
(0.05) 
  
 
Sore throat 11 (3 - 25) 95 (0) 11 (0 - 25) 95 (0) n/a n/a n/a n/a 11 (0 - 25) 95 (0) 11 (0 - 25) 95 (0) n/a n/a 
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  Musculoskeletal (MSK) 
  
  
   
  
  
  
   
  
  
 
Limb pain n/a n/a n/a  n/a n/a n/a n/a  n/a n/a n/a n/a n/a n/a n/a 
  
 
Bone pain 26 (17 - 35) 97 (0) 10 (5 - 15) 78 (0) 33 (20 - 46) 97 (0) 
32 (18 - 
45) 
97 (0) 15 (7 - 22) 89 (0) 23 (19 - 26) 
12 
(0.34) 
16 (3 - 36) 
79 
(0.03) 
  
 
MSK impairment n/a n/a n/a  n/a n/a n/a n/a  n/a n/a n/a n/a n/a n/a n/a 
  
 
Bone and/or joint pain 19 (13 - 25) 76 (0) 17 (9 - 26) 83 (0) 20 (14 - 25) 
0 
(0.43) 
22 (12 - 
31) 
76 (0) 15 (8 - 22) 
71 
(0.02) 
19 (11 - 28) 86 (0) 19 (8 - 30) 
55 
(0.11) 
  
 
Joint pain 15 (5 - 25) 96 (0) 19 (11 - 27) 
57 
(0.1) 
13 (0 - 28) 98 (0) 15 (1 - 29) 97 (0) 14 (0 - 34) 97 (0) 21 (0 - 49) 98 (0) n/a n/a 
  
 
Limp 11 (0 -21) 
94 
(0.05) 
6 (0 - 12) 
72 
(0.03) 
n/a n/a 11 (0 - 21) 94 (0) n/a n/a n/a n/a n/a n/a 
  
 
  
  
  
   
  
  
  
   
  
  Systemic 
  
  
   
  
  
  
   
  
  
 
Pallor 54 (40-69) 99 (0) 34 (15 - 52) 98 (0) 73 (61 - 85) 96 (0) 
63 (50 - 
75) 
96 (0) 
42 (19 - 
64) 
99 (0) 60 (44 - 76) 97 (0) 
57 (0 - 
100) 
99 (0) 
  
 
Fatigue 46 (28 - 64) 97 (0) 39 (8 - 71) 98 (0) 47 (0 - 94) 98 (0) 
43 (23 - 
63) 
97 (0) n/a n/a 42 (18 - 66) 98 (0) n/a n/a 
  
 
Malaise/fatigue 31 (7 - 56) 97 (0) 41 (11 - 70) 93 (0) n/a n/a n/a n/a 37 (0 - 77) 97 (0) 32 (0 - 87) 98 (0) 31 (0 - 64) 92 (0) 
  
 
Weakness/fatigue 27 (18 - 36) 94 (0) 26 (18 - 34) 84 (0) 29 (9 - 50) 97 (0) 
42 (20 - 
63) 
95 (0) 15 (7 - 23) 87 (0) 25 (16 - 33) n/a n/a n/a 
  
 
Oedema 15 (10 - 20) 0 (0.58) n/a n/a 15 (10 - 21) 
0 
(0.51) 
20 (0 - 45) 
17 
(0.27) 
15 (10 - 
22) 
0 14 (7 - 20) 0 (0.6) n/a n/a 
  
 
  
  
  
   
  
  
  
   
  
  Gastro-intestinal 
  
  
   
  
  
  
   
  
  
 
Anorexia/weight loss 29 (16 - 42) 97 (0) 22 (15 - 28) 77 (0) 43 (14 - 73) 98 
24 (15 - 
33) 
90 (0) 38 (4 - 73) 99 (0) 31 (15 - 48) 98 
19 (13 - 
26) 
0 (0.65) 
  
 
Abdominal symptoms 20 (9 - 31) 89 (0) 20 (9 - 31) 89 (0) n/a n/a 
38 (24 - 
52) 
83 (0) 14 (5 - 23) 89 (0) 21 (3 - 34) 82 
38 (24 - 
52) 
0 (0.81) 
  
 
Abdominal pain 12 (7 - 16) 49 (0) 15 (7 - 24) 
64 
(0.02) 
10 (6 - 15) 0 
15 (10 - 
21) 
14 
(0.33) 
8 (5 - 11) 
12 
(0.29) 
11 (7 - 15) 0 n/a n/a 
  
 
Abdominal distension 11 (3 - 18) 87 (0.1) 8 (0 - 16) 89 (0) 12 (3 - 21) 87 8 (1 - 15) 82 (0) n/a n/a 30 (0 - 84) 92 9 (1 - 16) 0 (0.43) 
  
 
  
  
  
   
  
  
  
   
  
  Cutaneous 
  
  
   
  
  
  
   
  
  
 
Rash 35 (22 - 48) 72 33 (16 - 49) 77 (0) 43 (25 - 62) 29 
41 (27 - 
56) 
62 
(0.03) 
20 (9 - 31) 0 (0.6) 31 (19 - 43) 60 n/a n/a 
  
 
Pyoderma n/a  n/a n/a  n/a n/a n/a n/a  n/a n/a n/a n/a n/a n/a n/a 
  
 
Nodules n/a  n/a n/a  n/a n/a n/a n/a  n/a n/a n/a n/a n/a n/a n/a 
  
 
Skin infiltration 12 (11 - 36) 97 n/a  n/a n/a n/a n/a  n/a n/a n/a 12 (0 - 36) 97 n/a n/a 
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